MedTrace Logo

Maxolon to Improve Breastmilk Supply in Diabetic Women: a Randomised Controlled Trial

NCT00477776 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2009-09-21

No results posted yet for this study

Summary

Early use of oral maxalon can hasten and improve the establishment of breastfeeding in diabetic mothers after preterm and term deliveries.

Maxolon promotes breastfeeding by working on the central nervous system which increases the milk producing hormone, prolactin which in turn helps to increase the milk supply for breastfeeding. Successful early breastfeeding establishment is important for continued breastfeeding.

Conditions

  • Breastfeeding

Interventions

DRUG

Metoclopramide (Maxolon)

Metoclopramide 10 mg 3 times a day for 7 days, 2 times a day from day 8 to day 10, once a day for day 11 and 12

DRUG

Placebo

Placebo 10 mg 3 times a day for 7 days, 2 times a day from day 8 to 10, once a day from day 11 to 12

Sponsors & Collaborators

  • The University of Western Australia

    collaborator OTHER

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Chong Y S, MBBS,MRACOG · National University Hospital and National University of Singapore

  • Citra Mattar, MBBS · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2008-09-30
Completion
2009-03-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00477776 on ClinicalTrials.gov